1stOncology™: Cancer Intelligence Service – Page 10087 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Gilead Sciences to Present at Upcoming Investor Conferences

On February 18, 2021 Gilead Sciences, Inc. (Nasdaq: GILD) reported that its executives will be speaking at the following investor conferences (Press release, Gilead Sciences, FEB 18, 2021, View Source [SID1234575287]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:40 p.m. EST
Cowen Annual Health Care Conference on Thursday, March 4, 2021 at 12:10 p.m. EST
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 14 days following the presentation.

Moderna to Present at Upcoming Investor Conferences in February and March 2021

On February 18, 2021 Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, reported its participation in the following upcoming virtual investor conferences (Press release, Moderna Therapeutics, FEB 18, 2021, View Source [SID1234575286]):

SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 1:00 p.m. ET.
Cowen & Co. 41st Annual Health Care Conference on Monday, March 1, 2021 at 8:00 a.m. ET (panel presentation).
Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 10:20 a.m. ET.
A live webcast of each presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna’s website for 30 days following the presentation.

Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021

On February 18, 2021 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that it will report its fourth quarter and full year 2020 financial results on Thursday, February 25, 2021 (Press release, Iovance Biotherapeutics, FEB 18, 2021, View Source [SID1234575285]). Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. EST.

To participate in the conference call, please dial 1-844-646-4465 (domestic) or 1-615-247-0257 (international) and reference the access code 9075827. The live webcast can be accessed in the Investors section of the Company’s website at www.iovance.com. The archived webcast will also be available for one year in the Investors section at www.iovance.com.

PACIRA TO REPORT 2020 FINANCIAL RESULTS ON THURSDAY FEBRUARY 25, 2021

On February 18, 2021 Pacira BioSciences, Inc. (NASDAQ:PCRX) reported that it will report its fourth quarter and year ended December 31, 2020 financial results before the open of the U.S. markets on Thursday, February 25, 2021 (Press release, Pacific Pharmaceuticals (Canada), FEB 18, 2021, View Source [SID1234575284]). Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET.

To participate in the conference call, dial 1-877-845-0779 and provide the passcode 4864607. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the "Events" page on the Pacira website at investor.pacira.com.

For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode 4864607. The replay of the call will be available for one week from the date of the live call. The webcast will be available on the Pacira website for approximately two weeks following the call.

FibroGen to Report Fourth Quarter and Full Year 2020 Financial Results

On February 18, 2021 FibroGen, Inc. (NASDAQ: FGEN) reported that it will announce its fourth quarter and full year 2020 financial results on Monday, March 1 after the market close. FibroGen will also conduct a conference call on that day at 5:00 p.m. ET (2:00 p.m. PT) with the investment community to further detail the company’s corporate and financial performance (Press release, FibroGen, FEB 18, 2021, View Source [SID1234575283]).

Conference Call and Audio Webcast
Interested parties may access a live audio webcast of the conference call via the FibroGen website at View Source It is recommended that listeners access the website 15 minutes prior to the start of the call to download and install any necessary audio software.

A replay of the webcast and investor presentation will be available shortly after the call for a period of 30 days. To access the replay, please dial (855) 859-2056 (domestic) or (404) 537-3406 (international), and use passcode 3055327.